Drugs / Fuzheng Yiliu Formulation
Fuzheng Yiliu Formulation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04459754 | Jun 2020 → Dec 2021 | colorectal cancer | Guangdong Provincial Hospital of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fuzheng Yiliu Formulation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04459754 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “combination of 13 herbal components” NCT04459754 ↗ |